SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-068532
Filing Date
2017-11-14
Accepted
2017-11-14 16:33:40
Documents
34
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20579_110q.htm 10-Q 765161
2 EX-31.1 a17-20579_1ex31d1.htm EX-31.1 9843
3 EX-31.2 a17-20579_1ex31d2.htm EX-31.2 10163
4 EX-32.1 a17-20579_1ex32d1.htm EX-32.1 5878
5 EX-32.2 a17-20579_1ex32d2.htm EX-32.2 6196
  Complete submission text file 0001104659-17-068532.txt   2086420

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtxi-20170930.xml EX-101.INS 255215
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gtxi-20170930.xsd EX-101.SCH 16577
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gtxi-20170930_cal.xml EX-101.CAL 20620
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gtxi-20170930_def.xml EX-101.DEF 36069
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gtxi-20170930_lab.xml EX-101.LAB 178173
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gtxi-20170930_pre.xml EX-101.PRE 114836
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 171202119
SIC: 2834 Pharmaceutical Preparations